Breast Cancer

Everolimus in Advanced HER2-Positive Breast Cancer With PIK3CA Mutation, PTEN Loss, or Hyperactive PI3K Pathway

In an analysis of the phase III BOLERO-1 and -3 trials reported in the Journal of Clinical OncologyFabrice André, MD, of Institut Gustav-Roussy, Paris, France, and colleagues found that...

Prostate Cancer

Continuation of Docetaxel May Improve Survival in Metastatic Castration-Resistant Prostate Cancer

The number of docetaxel cycles completed was associated with improved overall survival among men with metastatic castration-resistant prostate cancer receiving docetaxel, prednisone...

Colorectal Cancer

New USPSTF Recommendations for Colorectal Cancer Screening

As reported in JAMA, the U.S. Preventive Services Task Force ­(USPSTF) has issued new recommendations for colorectal cancer screening. In brief, the USPSTF recommends...


More Top Stories

Lung Cancer

Maria Werner-Wasik, MD, on Issues in Lung Toxicity

Breast Cancer

Nipple-Sparing Mastectomy Shown to Be Safe—and Increasingly Preferred

Prophylactic mastectomy that preserves a woman’s nipple is oncologically safe in patients with deleterious BRCA mutations, according to the largest study yet to evaluate this approach in this high-risk population. “In more than 500 risk-reducing nipple-sparing mastectomies in 348 deleterious...


ASTRO 2016: Extremely Hypofractionated Radiation Therapy Shows Promising Toxicity Results for Intermediate-Risk Prostate Cancer

For men with intermediate-risk prostate cancer, side effects at 2 years following radiation therapy were comparable for extremely hypofractionated treatment, which was delivered in 7 fractions across 2.5 weeks, and conventional treatment of 39 fractions across 8 weeks, according to research...

Prostate Cancer

Daniel Hamstra, MD, PhD, on Prostate Cancer: Decreasing Rectal Toxicity

President Obama Names Margaret Spitz, MPH, to National Cancer Advisory Board

Margaret Spitz, MPH, Professor in the National Cancer Institute (NCI)-designated Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been appointed by President Barack Obama as a member of the National Cancer Advisory Board (NCAB).

A renowned expert in molecular...

Issues in Oncology

Is Human Life Worth No More Than a Text Message?

The words “cost control,” “value-based health care,” and similar iterations are floating around freely these days to make us aware of the unsustainable upward trajectory of health-care costs. We are reminded constantly about how health care in America currently costs more than $3.4 trillion...

NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms

Myeloproliferative neoplasms are a group of blood cancers characterized by significant symptoms and a high risk of transformation into acute leukemia. These cancers—myelofibrosis, essential thrombocythemia, and polycythemia vera—affect approximately 13,000, 134,000, and 148,000 patients ...

Multiple Myeloma

S. Vincent Rajkumar, MD, and Sagar Lonial, MD, on Treating Multiple Myeloma

New: ASCO Answers Guide to Small Cell Lung Cancer

The new ASCO Answers Guide to Small Cell Lung Cancer can help people better understand their diagnosis and treatment options. Patients will find helpful, ASCO-approved information on treatment, follow-up care, and palliative care. The guide includes questions that patients can ask their...


Study Finds Statin Use Associated With Reduced Mortality in Multiple Myeloma

Analysis of data from the Veterans Administration Central Cancer Registry, reported in the Journal of Clinical Oncology by Sanfilippo et al, showed that statin use was associated with a reduced risk of all-cause and multiple myeloma–specific mortality in patients with multiple myeloma....

click me